Gross debt increased 31.0%
Gross debt changed +31.0% from the comparable as-filed period.
$2.0B→$2.6B0 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BBIO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Reported total debt increased 31.0%
Reported total debt changed +31.0% from the comparable as-filed period.
$2.0B→$2.6B0 prior comparisons
Cost of revenue increased 211.6%
Cost of revenue changed +211.6% from the comparable as-filed period.
$6.6M→$20.5M2 prior comparisons
Inventory increased 143.5%
Inventory changed +143.5% from the comparable as-filed period.
$24.5M→$59.7M1 prior comparisons
Research & development increased 27.1%
Research & development changed +27.1% from the comparable as-filed period.
$112.9M→$143.5M2 prior comparisons
Inventory / revenue moved 341 bp lower
Inventory / revenue changed -341 basis points from the comparable as-filed period.
20.32%→16.91%0 prior comparisons
Free-cash-flow margin moved 7858 bp higher
Free-cash-flow margin changed +7858 basis points from the comparable as-filed period.
-91.17%→-12.59%2 prior comparisons
Operating cash-flow margin moved 7828 bp higher
Operating cash-flow margin changed +7828 basis points from the comparable as-filed period.
-90.78%→-12.51%2 prior comparisons
R&D / revenue moved 5288 bp lower
R&D / revenue changed -5288 basis points from the comparable as-filed period.
93.52%→40.63%2 prior comparisons
Receivables / revenue moved 967 bp higher
Receivables / revenue changed +967 basis points from the comparable as-filed period.
96.54%→106.21%2 prior comparisons
Net debt decreased 19.6%
Net debt changed -19.6% from the comparable as-filed period.
$1.4B→$1.1B0 prior comparisons
Debt / revenue moved 91838 bp lower
Debt / revenue changed -91838 basis points from the comparable as-filed period.
1663.08%→744.70%0 prior comparisons
Debt / assets moved 7942 bp lower
Debt / assets changed -7942 basis points from the comparable as-filed period.
201.09%→121.66%0 prior comparisons
Cash / debt moved 2627 bp higher
Cash / debt changed +2627 basis points from the comparable as-filed period.
32.03%→58.30%0 prior comparisons
Capital expenditure decreased 38.3%
Capital expenditure changed -38.3% from the comparable as-filed period.
$470,000→$290,0002 prior comparisons
Gross margin moved 35 bp lower
Gross margin changed -35 basis points from the comparable as-filed period.
94.56%→94.21%2 prior comparisons
Capex / revenue moved 31 bp lower
Capex / revenue changed -31 basis points from the comparable as-filed period.
0.39%→0.08%2 prior comparisons
Stock-based compensation increased 13.0%
Stock-based compensation changed +13.0% from the comparable as-filed period.
$35.3M→$39.9M2 prior comparisons
Shares outstanding increased 1.1%
Shares outstanding changed +1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
192,708,813→194,800,7828 prior comparisons
Cost of revenue increased 311.9%
Cost of revenue changed +311.9% from the comparable as-filed period.
$3.7M→$15.0M2 prior comparisons
Inventory / revenue moved 515 bp higher
Inventory / revenue changed +515 basis points from the comparable as-filed period.
16.53%→21.69%0 prior comparisons
Free-cash-flow proxy increased 12.0%
Free-cash-flow proxy changed +12.0% from the comparable as-filed period.
-$81.3M→-$71.5M3 prior comparisons
Operating cash flow increased 11.9%
Operating cash flow changed +11.9% from the comparable as-filed period.
-$80.7M→-$71.1M3 prior comparisons
Net income increased 15.2%
Net income changed +15.2% from the comparable as-filed period.
-$183.8M→-$155.9M2 prior comparisons
Current assets increased 19.8%
Current assets changed +19.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$912.3M→$1.1B4 prior comparisons
Operating cash-flow margin moved 4379 bp higher
Operating cash-flow margin changed +4379 basis points from the comparable as-filed period.
-72.97%→-29.18%2 prior comparisons
R&D / revenue moved 3927 bp lower
R&D / revenue changed -3927 basis points from the comparable as-filed period.
100.60%→61.33%2 prior comparisons
Free-cash-flow margin moved 4415 bp higher
Free-cash-flow margin changed +4415 basis points from the comparable as-filed period.
-73.51%→-29.36%2 prior comparisons
Receivables / revenue moved 3491 bp higher
Receivables / revenue changed +3491 basis points from the comparable as-filed period.
69.52%→104.44%2 prior comparisons
Total assets increased 12.7%
Total assets changed +12.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.1B→$1.2B4 prior comparisons
Cash & equivalents decreased 9.5%
Cash & equivalents changed -9.5% from the comparable as-filed period.
$749.0M→$677.9M2 prior comparisons
Stock-based compensation increased 19.2%
Stock-based compensation changed +19.2% from the comparable as-filed period.
$37.3M→$44.5M2 prior comparisons
Capital expenditure decreased 25.4%
Capital expenditure changed -25.4% from the comparable as-filed period.
$594,000→$443,0002 prior comparisons
Capex / revenue moved 36 bp lower
Capex / revenue changed -36 basis points from the comparable as-filed period.
0.54%→0.18%2 prior comparisons
Shares outstanding increased 2.3%
Shares outstanding changed +2.3% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
191,168,504→195,487,4748 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.